IJMPD | Clinical characteristics of children with COVID-19 pneumonia

Indexing and Abstracting

Clinical characteristics of children with COVID-19 pneumonia

I. Y. Huseynova , A. Q. Hasanov , I. A. Gafarov

International Journal of Medical, Pharmacy and Drug Research(IJMPD), Vol-7,Issue-3, May - June 2023, Pages 1-8 , 10.22161/ijmpd.7.3.1

Download | Downloads : 7 | Total View : 361

Abstract:

For this purpose, 75 children under the age of 18 were included in the study. The test for SARS-CoV-2 virus RNA was positive in the pathological material from the nasopharynx in all examined patients. The control group consisted of 15 healthy children. The patients included in the study were divided into 2 groups according to severity of disease: 49 (65.3%) patients with moderate COVID-19 were included in group I, 26 (34.7%) patients with severe COVID-19 - in group 2. Examination methods included anamnestic, clinical, instrumental and laboratory studies. The most common symptoms among children examined were fever (66 (88.0%)) and cough (74 (98.7%)). Rarely, muscle pains, loss of sense of smell and taste, headaches have been observed in older children. Intergroup comparison revealed higher levels of ferritin, D-dimer and fibrinogen in group II compared with group I. According to the results obtained, the course of the disease in children, in contrast to adults, is more favorable.

Keywords:

COVID-19, children, clinical characteristics

References:

[1] Jiehao, C. A case series of children with 2019 novel coronavirus infection: clinical and epidemiological features // J. Clin. Infect. Dis. Publ. Infect. Dis. Soc. Am. 2020. v. 71, p.1547-1551.
[2] World Health Organization-Coronavirus disease 2020-who.int https://www.who/int/covid-19
[3] Lee P.J., Hu Y.L., Chen P.Y. et al. Are children less susceptible to COVİD-19. // J. Microbiol İmmunol İnfect. 2020, vol. 53(3), p. 371-372
[4] Yudan D., Haohao Y. Clinical characteristics of children with COVID-19: a meta-analysis. // J. Front Pediatrician. 2020, vol. 8, p.431
[5] Huseynova İ.Y., Hasanov A.Q., Qafarov İ.A. Predicting the Severity of COVID-19 Pneumonia in Children.// American Journal of Biomedical and Life Sciences. NewYork.2022, vol. 10(6): 176-184
[6] Ludvigsson, J.F. Systematik review of COVİD-19 in children show milder cases and a better prognosis than adult. // J. Acta Paediatr. 2020, vol. 109(6), p. 1088-1095.
[7] Martins M.M., Barbosa A. P. et al. Clinikal and laboratory characteristics of children with SARS-CoV-2 infection in children and adolescents. // Rev Paul Pediatr.2021, vol.39, p.2020231
[8] Dong Y., Mo X., Hu Y. et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. // J. Emerg Med. 2020,vol. 58(4), p.712-713.
[9] Petrov O.I., Pavelkina V.F., Shirmankina M.V. et al. Clinical and epidemiological features of the new coronavirus infection COVID-19 in children. // Modern problems of science and education. 2022, vol.3, p. 232-236
[10] Qian G., Zhang Y., Xu Y. et al. Reduced inflammatory respones to SARS-CoV-2 infection in children presenting to hospital with COVİD-19 in China. // Clinical Medicine.2021, vol.34, p. 100831
[11] Zou, Y., Guo H., Zhang Y. et al. Analysis of coagulation parameters in patients with COVİD-19 in Shanghai, China. // Biosci Trends. 2020,vol.14(4), p. 285-28
[12] Satış H., Özger H.S., Yıldız P.A. et al. Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVİD-19 // J. Cytokine. 2021, vol.137, p. 155-302
[13] Kausal K. Resident S., Kaur H. et al. Serum ferritin as a predictive biomarker in COVID-19. A systematic review, metanalysis and meta regression analysis. // J Crit Care. 2022,vol.67,p.171-181
[14] Hala K.Ş., Hanan M.L., Naglaa F. et al. Cytokine profiypfile in Egyptian children and adolescent with COVİD-19 pneumonia: A multicenter study. //Pediatr pulmonol.2021, vol. 56(12), p. 3924-3933
[15] Antonietta G., Carolina D’Anna, Stefania M. et al. Is COVID-19 a hyperferritinemic syndrome in children? // From the journal Clinical Chemistry and laboratory. doi.org/10.1515/cclm-2021-0373
[16] Saleh M., Alkofide A., Alshanmari A. Changes in hematological, clinical and laboratory parameters for children with COVİD-19: single-center experience. // J. blood Med. 2021,vol. 12,p. 819-826
[17] Han H., Yang L., Liu R. et al. Prominent changes in blood coagulation of patients with Sars-CoV-2 infection. // J. Clin. Chem Lab Med. 2020, vol. 58(7), p.1116-1120